These results indicate that NHE1 may exert suppressive effects on cell growth and malignancy through PI3K-AKT signaling in ESCC cells, and, thus, has potential as a new target for the treatment of ESCC. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.